BE878430A - Vaccins contre la pasteurellose - Google Patents
Vaccins contre la pasteurelloseInfo
- Publication number
- BE878430A BE878430A BE0/196885A BE196885A BE878430A BE 878430 A BE878430 A BE 878430A BE 0/196885 A BE0/196885 A BE 0/196885A BE 196885 A BE196885 A BE 196885A BE 878430 A BE878430 A BE 878430A
- Authority
- BE
- Belgium
- Prior art keywords
- vaccines against
- against pasteurellosis
- pasteurellosis
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7834525 | 1978-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE878430A true BE878430A (fr) | 1979-12-17 |
Family
ID=10499258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/196885A BE878430A (fr) | 1978-08-24 | 1979-08-24 | Vaccins contre la pasteurellose |
Country Status (12)
Country | Link |
---|---|
US (1) | US4346074A (xx) |
EP (1) | EP0020356B1 (xx) |
AU (1) | AU528776B2 (xx) |
BE (1) | BE878430A (xx) |
CA (1) | CA1133829A (xx) |
DE (1) | DE2964721D1 (xx) |
DK (1) | DK149942C (xx) |
IE (1) | IE48402B1 (xx) |
NO (1) | NO151225C (xx) |
NZ (1) | NZ191327A (xx) |
WO (1) | WO1980000412A1 (xx) |
ZA (1) | ZA794416B (xx) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293545A (en) | 1980-03-31 | 1981-10-06 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria vaccines |
US4328210A (en) | 1980-03-31 | 1982-05-04 | Norden Laboratories, Inc. | Modified Pasteurella bacteria and vaccines prepared therefrom |
US4335106A (en) | 1980-03-31 | 1982-06-15 | Norden Laboratories Inc. | Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom |
US4506017A (en) * | 1981-04-17 | 1985-03-19 | Norden Laboratories, Inc. | Modified Pasteurella haemolytica bacteria |
US4559306A (en) * | 1981-04-17 | 1985-12-17 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria |
US4626430A (en) * | 1981-04-17 | 1986-12-02 | Norden Laboratories, Inc. | Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871996A (en) * | 1994-02-04 | 1999-02-16 | Bio Merieux | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis |
JPS62162963A (ja) * | 1986-01-10 | 1987-07-18 | Sadao Shiosaka | 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法 |
US5165924A (en) * | 1986-01-22 | 1992-11-24 | University Of Guelph | Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle |
GB2202851B (en) * | 1987-03-24 | 1990-12-19 | Nat Res Dev | Proteinaceous material of p. haemolytica and vaccine against pasteurella |
US5256415A (en) * | 1989-03-20 | 1993-10-26 | Louisiana State University | Vaccine against bovine respiratory disease (pasteurellosis) |
US5273889A (en) * | 1990-08-22 | 1993-12-28 | University Of Saskatchewan | Gamma-iterferon-leukotoxin gene fusions and uses thereof |
US5594107A (en) * | 1990-08-22 | 1997-01-14 | University Of Saskatchewan | Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
US5238823A (en) * | 1990-08-22 | 1993-08-24 | Veterinary Infectious Disease Organization | Interleukin-2-leukotoxin gene fusions and uses thereof |
US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
MX9301736A (es) * | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
FR2689520B1 (fr) | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques. |
FR2689521B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture. |
US5534256A (en) * | 1992-07-02 | 1996-07-09 | University Of Saskatchewan | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
US5587305A (en) * | 1993-12-06 | 1996-12-24 | The United States Of America As Represented By The Department Of Agriculture | Pasteurella haemolytica transformants |
US6793927B1 (en) | 1993-12-06 | 2004-09-21 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
FR2716198B1 (fr) * | 1994-02-15 | 1996-04-19 | Bio Merieux | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
FR2737500B1 (fr) * | 1995-08-03 | 1997-08-29 | Bio Merieux | Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
ES2331496T3 (es) * | 1996-11-26 | 2010-01-05 | Bio Merieux | Material viral y fragmentos de nucleotidos asociados a la esclerosis multiple, para fines diagnosticos, profilacticos y terapeuticos. |
FR2760640B1 (fr) * | 1997-03-17 | 1999-05-28 | Vetoquinol Sa | Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica |
US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
US8541008B2 (en) * | 1999-11-19 | 2013-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against candidiasis |
JP2008504216A (ja) * | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | モノクローナル抗体の生成のための方法および組成物 |
CA2554755A1 (en) * | 2004-01-28 | 2005-08-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
US20090104114A1 (en) * | 2007-09-21 | 2009-04-23 | Cytimmune Sciences, Inc. | Nanotherapeutic Colloidal Metal Compositions and Methods |
CA2706700A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
CA2741691C (en) | 2008-11-05 | 2019-11-26 | Ingrid Lea Dodge | Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease |
JP2014521605A (ja) | 2011-07-22 | 2014-08-28 | ノバダイム セラピューティクス, インコーポレイテッド | Staphylococcusaureusに対してワクチン接種するための方法および組成物 |
AU2014227748B2 (en) | 2013-03-15 | 2019-02-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
WO2017155949A1 (en) | 2016-03-09 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1201052A (en) * | 1967-09-07 | 1970-08-05 | Lilly Co Eli | Vaccines |
US3526696A (en) * | 1968-02-14 | 1970-09-01 | Lilly Co Eli | Shipping fever vaccine |
GB1441098A (en) * | 1972-03-29 | 1976-06-30 | Wellcome Found | Biological preparations |
FR2360314A2 (fr) * | 1976-08-06 | 1978-03-03 | Fabre Sa Pierre | Nouveaux vaccins perfectionnes a base de fractions ribosomales |
-
1979
- 1979-08-16 US US06/194,122 patent/US4346074A/en not_active Expired - Lifetime
- 1979-08-16 DE DE7979900915T patent/DE2964721D1/de not_active Expired
- 1979-08-16 CA CA333,893A patent/CA1133829A/en not_active Expired
- 1979-08-16 NZ NZ191327A patent/NZ191327A/xx unknown
- 1979-08-16 WO PCT/GB1979/000141 patent/WO1980000412A1/en unknown
- 1979-08-21 ZA ZA00794416A patent/ZA794416B/xx unknown
- 1979-08-23 AU AU50214/79A patent/AU528776B2/en not_active Ceased
- 1979-08-23 IE IE1618/79A patent/IE48402B1/en not_active IP Right Cessation
- 1979-08-23 NO NO792748A patent/NO151225C/no unknown
- 1979-08-24 BE BE0/196885A patent/BE878430A/xx not_active IP Right Cessation
-
1980
- 1980-03-25 EP EP79900915A patent/EP0020356B1/en not_active Expired
- 1980-04-24 DK DK176480A patent/DK149942C/da not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293545A (en) | 1980-03-31 | 1981-10-06 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria vaccines |
US4328210A (en) | 1980-03-31 | 1982-05-04 | Norden Laboratories, Inc. | Modified Pasteurella bacteria and vaccines prepared therefrom |
US4335106A (en) | 1980-03-31 | 1982-06-15 | Norden Laboratories Inc. | Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom |
US4506017A (en) * | 1981-04-17 | 1985-03-19 | Norden Laboratories, Inc. | Modified Pasteurella haemolytica bacteria |
US4559306A (en) * | 1981-04-17 | 1985-12-17 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria |
US4626430A (en) * | 1981-04-17 | 1986-12-02 | Norden Laboratories, Inc. | Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom |
Also Published As
Publication number | Publication date |
---|---|
NZ191327A (en) | 1981-07-13 |
ZA794416B (en) | 1981-02-25 |
EP0020356A1 (en) | 1981-01-07 |
AU5021479A (en) | 1980-02-28 |
NO792748L (no) | 1980-02-26 |
AU528776B2 (en) | 1983-05-12 |
DK149942B (da) | 1986-11-03 |
NO151225B (no) | 1984-11-26 |
EP0020356B1 (en) | 1983-02-09 |
DE2964721D1 (en) | 1983-03-17 |
US4346074A (en) | 1982-08-24 |
NO151225C (no) | 1985-03-06 |
WO1980000412A1 (en) | 1980-03-20 |
IE48402B1 (en) | 1985-01-09 |
DK149942C (da) | 1987-05-04 |
IE791618L (en) | 1980-02-24 |
DK176480A (da) | 1980-04-24 |
CA1133829A (en) | 1982-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE878430A (fr) | Vaccins contre la pasteurellose | |
FI793951A (fi) | Stroemningsmaetare fungerande med ultraljud | |
MC1257A1 (fr) | Derive pyrrolidinique | |
BE858992A (fr) | Procede de preparation de vaccins | |
BE851880A (fr) | Vaccins vivants ameliores contre la pseudopeste aviaire | |
NL7804660A (nl) | Verbeterde vaccins. | |
ATA16078A (de) | Drehmomentenstuetze | |
BE832967A (fr) | Vaccins contre les enterites | |
AT356248B (de) | Audiometer | |
FI792159A (fi) | Foerbindning med ogivalspetsig laosdel e dyl | |
NO792329L (no) | 1-fenyl-1-propanol-derivater. | |
DK383079A (da) | Vaccine | |
ZA796820B (en) | Vaccines | |
AU525504B2 (en) | Intra-respiratory vaccine | |
GB2048066B (en) | Rabies vaccine | |
GB2029219B (en) | Pasteurellosis vaccines | |
ZA794399B (en) | Vaccine | |
AU527659B2 (en) | Anti-clostridiosis vaccine | |
RO79877A (ro) | Procedeu pentru obtinerea unor tulpini bacteriene inalt imunogene | |
SE7804124L (sv) | Vaccinstabiliseringsmedel | |
SE7810038L (sv) | Extraktionsforfarande | |
NL191729C (nl) | Gestabiliseerd vaccin. | |
BR5801487U (pt) | Travesseiro anti-sufocamento | |
BR5800823U (pt) | Travesseiro | |
AR214132A1 (es) | Almohada mejorada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: BRITISH TECHNOLOGY GROUP LTD Effective date: 19930831 |